Calidi Biotherapeutics In... (CLDI)

NYSE American: CLDI · 실시간 가격 · USD

1.59

+0.05 (3.25%)

종가 기준: Aug 14, 2026, 3:59 PM

1.60

+0.63%

애프터마켓: 7:55 PM

3.25% (1D)

매수호가	1.55
시가총액	3.89M
매출 (ttm)	n/a
순이익 (ttm)	-23.45M
베타	n/a
EPS (ttm)	-66.72
P/E (ttm)	n/a
선행 P/E	-1.77
P/B (ttm)	0.72
P/S (ttm)	n/a
Earnings Date	n/a

매도호가	1.77
거래량	149,339
평균 거래량 (20일)	320,942
시가	1.50
전일 종가	1.54
일중 범위	1.51 - 1.63
52주 범위	1.49 - 81.84
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

CLDI 소개

Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-40...

[더 보기]

산업 Biotechnology

섹터 Healthcare

IPO 일자 Nov 1, 2021

직원 수 29

상장 거래소 NYSE American

티커 CLDI

웹사이트 https://www.calidibio.com

전체 기업 정보